BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $246,682 | +6.6% | 6,380 | +4.1% | 0.01% | -11.1% |
| Q3 2023 | $231,322 | -50.1% | 6,129 | -39.7% | 0.01% | -47.1% |
| Q2 2023 | $463,208 | +57.4% | 10,167 | +40.1% | 0.02% | +54.5% |
| Q1 2023 | $294,287 | +97346.0% | 7,255 | +22.6% | 0.01% | -15.4% |
| Q4 2022 | $302 | -99.9% | 5,919 | -2.2% | 0.01% | -13.3% |
| Q3 2022 | $326,000 | -13.1% | 6,052 | +3.8% | 0.02% | -6.2% |
| Q2 2022 | $375,000 | -16.9% | 5,832 | +0.4% | 0.02% | 0.0% |
| Q1 2022 | $451,000 | -14.3% | 5,810 | -5.2% | 0.02% | -5.9% |
| Q4 2021 | $526,000 | -82.5% | 6,126 | -83.6% | 0.02% | -84.3% |
| Q3 2021 | $3,007,000 | -13.3% | 37,384 | -13.3% | 0.11% | -13.6% |
| Q2 2021 | $3,470,000 | -18.8% | 43,100 | -15.0% | 0.12% | -24.2% |
| Q1 2021 | $4,275,000 | +9.1% | 50,693 | +3.8% | 0.16% | +3.8% |
| Q4 2020 | $3,919,000 | -15.0% | 48,844 | -14.8% | 0.16% | -25.4% |
| Q3 2020 | $4,612,000 | -7.2% | 57,349 | -0.6% | 0.21% | -15.1% |
| Q2 2020 | $4,968,000 | +7.0% | 57,703 | +0.9% | 0.25% | -7.7% |
| Q1 2020 | $4,645,000 | -13.1% | 57,215 | -10.5% | 0.27% | +13.3% |
| Q4 2019 | $5,345,000 | +4.8% | 63,926 | +9.7% | 0.24% | +0.4% |
| Q3 2019 | $5,098,000 | +8.9% | 58,285 | +1.9% | 0.24% | +7.2% |
| Q2 2019 | $4,683,000 | +35.5% | 57,180 | +34.5% | 0.22% | +32.7% |
| Q1 2019 | $3,456,000 | +45.5% | 42,508 | +17.8% | 0.17% | +26.3% |
| Q4 2018 | $2,375,000 | +554.3% | 36,088 | +665.9% | 0.13% | +638.9% |
| Q3 2018 | $363,000 | +2.3% | 4,712 | -1.9% | 0.02% | -21.7% |
| Q2 2018 | $355,000 | +13.8% | 4,804 | 0.0% | 0.02% | +15.0% |
| Q1 2018 | $312,000 | +0.3% | 4,804 | 0.0% | 0.02% | +5.3% |
| Q4 2017 | $311,000 | +3.3% | 4,804 | 0.0% | 0.02% | -17.4% |
| Q3 2017 | $301,000 | +3.1% | 4,804 | -0.3% | 0.02% | -4.2% |
| Q2 2017 | $292,000 | +7.0% | 4,820 | -8.6% | 0.02% | +14.3% |
| Q1 2017 | $273,000 | +16.7% | 5,272 | 0.0% | 0.02% | +5.0% |
| Q4 2016 | $234,000 | -2.9% | 5,272 | +4.1% | 0.02% | -28.6% |
| Q3 2016 | $241,000 | +13.1% | 5,066 | +7.5% | 0.03% | +12.0% |
| Q2 2016 | $213,000 | -34.1% | 4,714 | +2.2% | 0.02% | -19.4% |
| Q2 2015 | $323,000 | -83.2% | 4,614 | -83.5% | 0.03% | -81.3% |
| Q1 2015 | $1,920,000 | -26.6% | 28,024 | -21.5% | 0.17% | -30.0% |
| Q4 2014 | $2,617,000 | +17.2% | 35,714 | +15.6% | 0.24% | +27.4% |
| Q2 2014 | $2,233,000 | +42.0% | 30,891 | +36.6% | 0.19% | +16.2% |
| Q4 2013 | $1,573,000 | +420.9% | 22,619 | +392.4% | 0.16% | +400.0% |
| Q3 2013 | $302,000 | -5.3% | 4,594 | 0.0% | 0.03% | -15.8% |
| Q2 2013 | $319,000 | – | 4,594 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |